No fee unless we recover compensation for your family Text size 833-4-ASBESTOS (833-427-2378) Free Case Review

U.S. Mineral Products Asbestos Trust Annual Reports, 2020–2025

You don't need the product names or old records. No fee unless we recover compensation for your family.

Call 833-4-ASBESTOS Request a review

The United States Mineral Products Company Asbestos Personal Injury Settlement Trust reports to the U.S. Bankruptcy Court for the District of Delaware each year on its finances and the claims it paid. Below are its 5 annual reports, 2020 to 2025, each with our summary of the year. Read any report online or download the PDF.

Filed by
United States Mineral Products Company Asbestos Personal Injury Settlement Trust
Fiscal years
2020–2025
Rights
Filed with the U.S. Bankruptcy Court for the District of Delaware, case no. 01-02471. Public court records, republished for public information.
Official copy
www.usmineraltrust.com/
U.S. Mineral Products trust: net assets, claims paid and payment percentage, 2020–2025U.S. Mineral Products net assets went from $33.6M at the end of 2020 to $29.1M at the end of 2025. Claims paid ranged from $293K (2021) to $2.9M (2022). Payment percentage: 30.0% from January 1, 2019; 15.0% from April 21, 2021; 32.0% from March 5, 2024.Net assets at year end$0$10M$20M$30M$40M$33.6M$29.1MClaims paid each year, and the payment percentage$0$750K$1.5M$2.3M$3M2020: $1.6M paid2021: $293K paid2022: $2.9M paid2023: $1.1M paid2025: $2.6M paid30.0%15.0%32.0%202020212022202320242025
From the trust’s annual reports. Net assets are what the trust held for claimants at the end of each year; claims paid is what it paid on approved claims that year; the payment percentage is the share of each claim’s value it paid, shown from the date each rate took effect.

U.S. Mineral Products 2025 annual report

Filed September 10, 2026

US Mineral reported year-end 2025 net claimants’ equity of $29.14 million, down $1.49 million from $30.63 million. Claim payments of $2.59 million exceeded $1.10 million in comprehensive income. The Trust received $1.02 million in excess cash from USM and recorded $651,560 in combined unrealized securities gains and growth in the holding-company investment. Operating, administrative and interest deductions totaled $888,684, including $355,285 in interest expense, compared with $69,890 of interest in 2024. Claims paid were substantially below the $8.12 million reported for 2024, which included approximately $5.69 million in supplemental payments following the increase to a 32% payment percentage.

The face statements report $40.52 million in total assets and $11.38 million in notes payable to USM. Assets included a $28.68 million holding-company investment and a separate $2.50 million receivable, so total assets should not be read as immediately available cash. Borrowing and its rising interest cost are significant features of the funding picture. The borrowing disclosures also contain a timing inconsistency: the reported year-end note balance includes an amount that Note 8 dates to February 2026. These figures follow the face statements; the report does not reconcile that discrepancy.

U.S. Mineral Products 2023 annual report

Filed August 29, 2024

US Mineral ended 2023 with net claimants’ equity of $36.58 million, up $8.05 million from $28.53 million after $1.14 million in claim payments. The principal driver was an $8.37 million increase in the recorded value of its interest in USM Holding Company LLC following USM’s August asset sale for $30 million, with approximately $28.96 million in net proceeds at the company level. The Trust also recorded $712,618 in unrealized securities gains and received an $800,000 excess-cash distribution from USM. Operating and administrative deductions totaled $768,689, and comprehensive income before claim payments was $9.19 million.

The increase in the holding-company investment should be distinguished from cash distributed directly to the Trust. At year-end, the Trust reported $26.57 million in that investment and a $1.45 million note payable to USM. The sale prompted a payment-percentage review, and the report describes the subsequent March 2024 approval of an increase from 15% to 32%, together with qualifying supplemental payments. Those changes and the resulting supplemental distributions occurred after the 2023 reporting year.

U.S. Mineral Products 2022 annual report

Filed April 27, 2023

US Mineral’s net claimants’ equity declined by $5.25 million in 2022, from $33.78 million to $28.53 million. The decline combined $2.85 million in claim payments with a $2.40 million comprehensive loss, driven chiefly by $2.55 million in unrealized investment losses. Investment-related additions of $804,723, including $602,908 in annuity income, exceeded operating and administrative deductions of $652,979; however, that positive result before valuation changes was insufficient to offset the investment losses. No excess-cash distribution was received from USM.

Claims paid increased substantially from $292,628 in 2021, but $1.30 million of the 2022 total represented claims approved and outstanding at the prior year-end and paid in January. The increase therefore partly reflects payment timing rather than solely new claims activity. The report continued to describe the 15% payment percentage adopted in 2021. Overall, both distributions to claimants and weaker investment valuations reduced the reported asset base during the year.

U.S. Mineral Products 2021 annual report

Filed April 28, 2022

US Mineral ended 2021 with net claimants’ equity of $33.78 million, an increase of $128,981 from $33.65 million. Investment-related additions of $448,567 fell short of $682,350 in operating and administrative deductions, but $655,392 in unrealized investment gains brought comprehensive income before claim payments to $421,609. The financial statements report $292,628 in claims paid. Unlike 2020, the Trust received no excess-cash distribution from USM, making investment performance particularly important to the year’s result.

The Trust approved a reduction in its payment percentage from 30% to 15% in April 2021, subject to a grace period and specified treatment of existing offers. The report attributes the reassessment to higher-than-forecast claims and uncertainty about the pandemic’s effects and future USM distributions. The low cash payout for the year also reflects timing: $1.30 million of approved claims remained outstanding at December 31 and was paid in January 2022. That subsequent payment is important context for the small increase in reported year-end equity.

U.S. Mineral Products 2020 annual report

Filed April 29, 2021

US Mineral ended 2020 with net claimants’ equity of $33.65 million, up $237,697 from $33.41 million. The financial statements report $1.61 million in claim payments and $1.15 million in operating and administrative deductions, including $401,731 in legal expenses and $333,263 in claims-processing and related expenses. A $1.90 million excess-cash distribution from USM was the principal funding contribution, supplemented by investment income and $753,220 in unrealized investment gains. Together, these produced $1.85 million in comprehensive income before claim payments.

The modest increase in equity occurred during a disrupted claims year: the Trust changed claims processors, suspended processing and payments for part of the year, and restricted new settlement activity while reviewing the sustainability of its 30% payment percentage. The report identifies increased claim filings and uncertainty over future USM distributions as pressures on funding. Claim payments were also far below 2019, when payments included roughly $10 million in catch-up distributions, so the year-to-year decline should not be interpreted as a comparable reduction in underlying claims demand.

Cited on this site

Talk with an asbestos lawyer

Start with what you remember, and we'll take it from there.

This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.